logo-large
  • Browse Categories

Publications by authors named "Can Tuerksever"

Claim this Profile
H
Hypothetical Switch of Anti-Vascular Endothelial Growth Factor in Neovascular Age-Related Macular Degeneration: An ARIES Post Hoc Analysis.
Cengiz Tuerksever, Gábor Márk Somfai, Susanne Oesch, Tobias Machewitz, Pascal W Hasler

Ophthalmol Ther· April 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency SD-OCT follow-up leading to up to biweekly intravitreal ranibizumab treatment in neovascular age-related macular degeneration.
Cengiz Tuerksever, Christian Pruente, Katja Hatz

Sci Rep· March 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia.
Maria-Magdalena Guichard, Géraldine Peters, Cengiz Tuerksever, Christian Pruente, Katja Hatz

Ophthalmologica· January 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
Katja Hatz, Andreas Ebneter, Cengiz Tuerksever, Christian Pruente, Martin Zinkernagel

Ophthalmologica· June 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: